Transcription of Section 3 Pharmaceutical Form - European Medicines Agency
{{id}} {{{paragraph}}}
An Agency of the European Union Section 3: Pharmaceutical form SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) SmPC Advisory Group Index objectives principles Term for Pharmaceutical form Description of Pharmaceutical form Section 3: Pharmaceutical form 2 I. General objectives of Section 3 Section 3: Pharmaceutical form 3 This Section should state the Pharmaceutical form according to the European pharmacopoeia and a visual description of the product Section index Term for Pharmaceutical form Section 3: Pharmaceutical form 4 If a patient friendly term (formerly short term) of the European pharmacopoeia is used on small immediate packaging material, the patient friendly term should be added in brackets in this Section (subscription only access) Should be described by a full standard term of European pharmacopoeia usi
according to the European Pharmacopoeia and a visual description of the product. Section index. II.1 Term for pharmaceutical form 4 Section 3: Pharmaceutical form If a patient friendly term (formerly short term) of the European Pharmacopoeia is used on small immediate packaging material
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}